These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6541807)

  • 1. Separation of morphine analgesia from physical dependence.
    Ling GS; MacLeod JM; Lee S; Lockhart SH; Pasternak GW
    Science; 1984 Oct; 226(4673):462-4. PubMed ID: 6541807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence.
    Mori T; Komiya S; Uzawa N; Inoue K; Itoh T; Aoki S; Shibasaki M; Suzuki T
    Eur J Pharmacol; 2013 Sep; 715(1-3):238-45. PubMed ID: 23707904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of morphine analgesia by intracerebroventricular naloxonazine.
    Simone DA; Bodnar RJ; Portzline T; Pasternak GW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1721-7. PubMed ID: 3016762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms.
    Ling GS; Spiegel K; Lockhart SH; Pasternak GW
    J Pharmacol Exp Ther; 1985 Jan; 232(1):149-55. PubMed ID: 2981312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes.
    Kim DH; Fields HL; Barbaro NM
    Brain Res; 1990 May; 516(1):37-40. PubMed ID: 2163724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of yohimbine on morphine analgesia and physical dependence in the rat.
    Iglesias V; Alguacil LF; Alamo C; Cuenca E
    Eur J Pharmacol; 1992 Jan; 211(1):35-8. PubMed ID: 1618266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different receptors mediate morphine-induced prolactin and growth hormone release.
    Spiegel K; Kourides IA; Pasternak GW
    Life Sci; 1982 Nov 15-22; 31(20-21):2177-80. PubMed ID: 6298516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The physical dependence liabilities of oxybutynin and morphine in rats.
    Algate DR; Beard DJ
    Arzneimittelforschung; 1985; 35(10):1577-9. PubMed ID: 4074417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of ketamine, naloxone and morphine in the rat.
    Fidecka S
    Pol J Pharmacol Pharm; 1987; 39(1):33-40. PubMed ID: 3671186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphrine: demonstration of physical dependence liability.
    Dum J; Bläsig J; Herz A
    Eur J Pharmacol; 1981 Mar; 70(3):293-300. PubMed ID: 6262095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of plasma catecholamines in eliciting cardiovascular changes seen during naloxone-precipitated withdrawal in conscious, unrestrained morphine-dependent rats.
    Chang AP; Dixon WR
    J Pharmacol Exp Ther; 1990 Sep; 254(3):857-63. PubMed ID: 2395117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine induced analgesia is attenuated in post-partum lactating rats.
    Janik J; Callahan P; Rabii J
    Life Sci; 1993; 52(3):271-9. PubMed ID: 8380878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the intraplantar injection of lidocaine and morphine on pain perception and the influence of morphine dependence and withdrawal on lidocaine-induced analgesia in rats.
    Moini Zanjani T; Sabetkasaei M
    Iran Biomed J; 2010 Oct; 14(4):164-70. PubMed ID: 21283259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone precipitates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Carter VA; Cunningham JS; Wilson OB
    Psychopharmacology (Berl); 1993; 112(2-3):339-42. PubMed ID: 7871039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of naloxone-induced analgesia by pretreatment with morphine.
    Cappell H; Poulos CX; Lê AD
    Pharmacol Biochem Behav; 1989 Oct; 34(2):425-7. PubMed ID: 2560204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical dependence of a dermorphin tetrapeptide analog, [D-Arg2, Sar4]-dermorphin (1-4) in the rat.
    Nakata N; Sakurada S; Sakurada T; Kisara K; Sasaki Y; Suzuki K
    Pharmacol Biochem Behav; 1986 Jan; 24(1):27-31. PubMed ID: 3945663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxonazine actions in vivo.
    Ling GS; Simantov R; Clark JA; Pasternak GW
    Eur J Pharmacol; 1986 Sep; 129(1-2):33-8. PubMed ID: 3021478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.
    Kamei J; Ohsawa M; Saitoh A; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    J Pharmacol Exp Ther; 1995 Aug; 274(2):700-6. PubMed ID: 7636731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.